|
Volumn 49, Issue 2, 2001, Pages 227-228
|
New drugs for old folks: The evidence-based argument for newer antidepressants
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE;
HYPNOTIC SEDATIVE AGENT;
NORTRIPTYLINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
AGED;
DEPRESSION;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
GERIATRIC PATIENT;
GERONTOPSYCHIATRY;
HUMAN;
HYPERICUM PERFORATUM;
MENTAL DISEASE;
NURSING HOME;
PSYCHOPHARMACOTHERAPY;
PSYCHOTHERAPY;
SHORT SURVEY;
AGED;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
DEPRESSIVE DISORDER;
EVIDENCE-BASED MEDICINE;
HUMANS;
PATIENT SELECTION;
RESEARCH DESIGN;
SAFETY;
SEROTONIN UPTAKE INHIBITORS;
TREATMENT OUTCOME;
|
EID: 0035097375
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1532-5415.2001.49043.x Document Type: Article |
Times cited : (1)
|
References (14)
|